Top

Journal of Hepato-Biliary-Pancreatic Sciences

Published in:

01-03-2011 | Original article

Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis

Authors: Hitoshi Sano, Takahiro Nakazawa, Tomoaki Ando, Kazuki Hayashi, Itaru Naitoh, Fumihiro Okumura, Katsuyuki Miyabe, Michihiro Yoshida, Satoru Takahashi, Hirotaka Ohara, Takashi Joh

Published in: Journal of Hepato-Biliary-Pancreatic Sciences | Issue 2/2011

Abstract

Purpose

Only a few studies have documented the characteristics of inflammatory bowel disease (IBD) associated with primary sclerosing cholangitis (PSC). We aimed to clarify the clinical and histopathological characteristics of IBD associated with PSC (PSC-IBD).

Methods

Twenty-nine patients with PSC and 60 patients with ulcerative colitis (UC) but without complicating PSC were enrolled in this study. First, the age and sex distribution, affected area, clinical course, number of recurrent attacks, and severity of UC were investigated. Then, mucosal specimens obtained from the right side (cecum and ascending colon), transverse colon, and the left side (descending colon, sigmoid colon, and rectum) during colonoscopy were studied for inflammatory cell infiltration, the presence of crypt abscesses, the degree of goblet cell disappearance, and edema.

Results

(1) The incidence of IBD in PSC patients was 68.9% (20/29). There were two peaks in the age distribution of PSC. Male PSC patients demonstrated a first peak and female patients a second peak. Male PSC-IBD patients were in their teens and 20s making the first peak. Female PSC-IBD patients were in their 50s and 60s making the second peak. The PSC-IBD patents were significantly younger than the patients without IBD (33.6 vs. 58.9 years, p < 0.001). (2) PSC-IBD showed a right-sided predominance colonoscopically. (3) None of the patients had a severe clinical course, and a half of them were asymptomatic. (4) Histopathological examination demonstrated severe inflammatory cell infiltration in the cecum and ascending colon, whereas the degree was mild in the rectum/descending colon.

Conclusions

PSC-IBD shows characteristic clinical, colonoscopic, and histopathological findings.

Vierling JM. In: Manns P, Chapman RW, Stiehl A, et al., editors. Primary sclerosing cholangitis. London: Kluwer; 1988. p. 37–45.

Lazaridis KN, Wiesner RH, Porayko MK, Ludwig J, LaRusso NF. Primary sclerosing cholangitis. In: Schiff ER, Sorrel MF, Maddrey WC, editors. Schiff’s disease of the liver. English Edition. Philadelphia: Lippincott-Raven; 1999. p. 649–78.

Lindor KD, LaRusso NF. Primary sclerosing cholangitis. In: Schiff L, Schiff ER, editors. Schiff’s disease of the liver, Nineth edition. Philadelphia: JB Lippincott; 2003. p. 673–84.

Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;430–36.

Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan—analysis of 192 cases. J Gastroenterol. 1997;32:134–7.PubMedCrossRef

Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan. Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004;29:153–9.PubMedCrossRef

Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, et al. PSC–IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91–6.PubMedCrossRef

Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, et al. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol. 2008;14:3497–503.PubMedCrossRef

Uchida N, Ezaki T, Fukuma H, Tsutsui K, Kobara H, Matsuoka M, et al. Concomitant colitis associated with primary sclerosing cholangitis. J Gastroenterol. 2003;38:482–7.PubMedCrossRef

10.

Oshitani N, Jinno Y, Sawa Y, Nakamura S, Matsumoto T, Nishiguchi S, et al. Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis? Hepatogastroenterology. 2003;50:1830–5.PubMed

11.

Yamagishi N, Iizuka B. Ulcerative colitis and primary sclerosing cholangitis: colonoscopic features of concomitant colitis with primary sclerosing cholangitis (in Japanese). Kan Tan Sui. 2004;49:221–8.

12.

Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn’s disease. Hepatogastroenterology. 1990;27:18–31.

13.

Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease-“colitis indeterminate”. J Clin Pathol. 1978;31:567–77.PubMedCrossRef

14.

Lee KS, Medline A, Shockey S. Indeterminate colitis in the spectrum of inflammatory bowel disease. Arch Pathol Lab Med. 1979;103:173–6.PubMed

15.

Matsui T, Yao T, Sakurai T, Yao K, Hirai F, Matake H, et al. Clinical features and pattern of indeterminate colitis: Crohn’s disease with ulcerative colitis-like clinical presentation. J Gastroenterol. 2003;38:647–55.PubMedCrossRef

16.

Hiwatashi N. Criteria for diagnosis of ulcerative colitis (preliminary proposal). In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan; 1993. p. 90–2.

17.

Gilaad GK, Kevin BL, Decker B, Stefan JU, Samuel SL. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007;102:1042–9.CrossRef

18.

Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20–5.PubMed

19.

Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholantis. Gastrointest Endosc. 2004;60:937–44.PubMedCrossRef

20.

Utsunomiya T, Katsumata T, Nakayama T, Kitahora T, Ohara S, Yokota H, et al. Prevalence of ulcerative colitis (1973–1991). In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan; 1993. p. 274–8.

21.

Bentley DW, Nicholos RL, Condon RE, Gorbach SL. The microflora of the human ileum and intra-abdominal colon: results of direct needle aspiration at surgery and evaluation of the technique. J Lab Clin Med. 1972;79:421–9.PubMed

22.

Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal PH profiles in normal ambulant human subjects. Gut. 1988;29:1035–41.PubMedCrossRef

23.

Nair PP, Gordon M, Reback J. The enzymatic cleavage of the carbon-nitrogen bond in 3a, 7a, 12a-trihydroxy-5b-cholan-24-oyl glycine. J Biol Chem. 1967;243:7–11.

24.

Stellwag EJ, Hylemon PB. 7a Dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum. J Lipid Res. 1979;20:325–33.PubMed

25.

Thomas LA, Veysey MJ, French G, Hylemon PB, Murphy GM, Dowling RH. Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples. Gut. 2001;49:835–42.PubMedCrossRef

26.

Palmer RH. Bile acids, liver injury, and liver disease. Arch Intern Med. 1972;130:606–17.PubMedCrossRef

27.

Yamada S, Ishii M, Liang LS, Yamamoto T, Toyota T. Small duct cholangitis induced by N-formyl l-methionine l-leucine l-tyrosine in rats. J Gastroenterol. 1994;29:631–6.PubMedCrossRef

28.

Morita N, Furuno S, Siraki K, Sawada T, Muto T, Tamakosi A, et al. Nationwide epidemiological survey of IBD. In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan; 1994. p. 176–83.

29.

Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1999;94:1643–9.PubMedCrossRef

30.

Brentnall TA. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996;110:331–8.PubMedCrossRef

31.

Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ Jr, LaRusso NF, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991;213:21–5.PubMedCrossRef

Title: Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis
Authors: Hitoshi Sano
Takahiro Nakazawa
Tomoaki Ando
Kazuki Hayashi
Itaru Naitoh
Fumihiro Okumura
Katsuyuki Miyabe
Michihiro Yoshida
Satoru Takahashi
Hirotaka Ohara
Takashi Joh
Publication date: 01-03-2011
Publisher: Springer Japan
Published in: Journal of Hepato-Biliary-Pancreatic Sciences / Issue 2/2011
Print ISSN: 1868-6974
Electronic ISSN: 1868-6982
DOI: https://doi.org/10.1007/s00534-010-0319-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2011

Donor quality of life after living donor liver transplantation: a prospective study

Technical refinements of bile duct division in living donor liver surgery

Large cystic acinar cell carcinoma of the pancreas

Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion

Robot-assisted laparoscopic pancreaticoduodenectomy

Complications of the treatment of endoscopic biliary strictures developing after liver transplantation